دورية أكاديمية

C40 - PerTe: efficacy and safety of pertuzumab in “real life setting” for the neoadjuvant treatment of HER2-positive breast cancer patients

التفاصيل البيبلوغرافية
العنوان: C40 - PerTe: efficacy and safety of pertuzumab in “real life setting” for the neoadjuvant treatment of HER2-positive breast cancer patients
المؤلفون: Cianniello, D., Prudente, A., Caputo, R., Piezzo, M., Riemma, M., Savastano, B., Cocco, S., Licenziato, M., De Stefano, B., Di Gioia, G., Fusco, G., Buonfanti, G., Gravina, A., Landi, G., Di Rella, F., Pacilio, C., Nuzzo, F., Iodice, G., De Laurentiis, M., Del Prete, S.
المصدر: In Annals of Oncology October 2017 28 Supplement 6:vi36-vi36
قاعدة البيانات: ScienceDirect
الوصف
تدمد:09237534
DOI:10.1093/annonc/mdx424.039